Drug Profile
Pregabalin - Pfizer
Alternative Names: CI 1008; Isobutylgaba; Lyrica; PD 144723Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Northwestern University
- Developer Eisai Co Ltd; Pfizer
- Class Aminobutyric acids; Analgesics; Antiepileptic drugs; Anxiolytics; Gabapentinoids; Neuroprotectants; Small molecules
- Mechanism of Action CACNA2D1 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Fibromyalgia; Generalised anxiety disorder; Neuropathic pain; Partial epilepsies; Postherpetic neuralgia
- No development reported Tonic-clonic epilepsy
- Discontinued Pain; Postoperative pain; Restless legs syndrome
Most Recent Events
- 01 Apr 2021 No development reported - Phase-III for Partial epilepsies (Adjunctive treatment, In children, In infants) in Belgium, Hungary, Germany, Spain, Belarus, Bulgaria, China, France, Greece, Israel, South Korea, Malaysia, Netherlands, Philippines, Romania, Russia, Serbia, Singapore, Slovakia, Taiwan, Thailand, Turkey, Poland, Portugal, Ukraine, Argentina, Bosnia-Herzegovina, Lebanon (PO, Liquid) (EudraCT2013-003420-37; NCT02072824)
- 01 Apr 2021 No development reported - Phase-III for Tonic-clonic epilepsy (Adjunctive treatment, In adolescents, In children, In adults) in Argentina, Austria, Belarus, Bosnia-Herzegovina, China, Croatia, Denmark, France, Greece, India, Lebanon, Montenegro, Philippines, Russia, Serbia, Slovakia, Spain, Turkey, Ukraine, United Kingdom, Lithuania, Netherlands, Estonia, Germany (PO, Capsule) (NCT01747915)
- 01 Apr 2021 No development reported - Phase-III for Tonic-clonic epilepsy (Adjunctive treatment, In adolescents, In children, In adults) in Argentina, Austria, Belarus, Bosnia-Herzegovina, China, Croatia, Denmark, France, Greece, India, Lebanon, Montenegro, Philippines, Russia, Serbia, Slovakia, Spain, Turkey, Ukraine, United Kingdom, Lithuania, Netherlands, Estonia, Germany (PO, Liquid) (NCT01747915)